Jacek J. Hawiger

Q: What Schools Are Affiliated With Jacek J. Hawiger

Jacek J. Hawiger is affiliated with the following schools: Harvard University, Vanderbilt University, University of Warsaw

Jacek J. Hawiger's AcademicInfluence.com Rankings

Jacek J. Hawiger

Philosophy

#9413

World Rank

#12967

Historical Rank

Logic

#6393

World Rank

#7907

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jacek J. Hawiger's Degrees

Doctorate Medicine University of Warsaw
PhD Biochemistry University of Warsaw

Why Is Jacek J. Hawiger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacek J. Hawiger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) (1995) (1001)
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. (1983) (671)
Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. (1984) (465)
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis (2005) (288)
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. (1989) (266)
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. (1970) (260)
Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. (1993) (245)
Innate immunity and inflammation: A transcriptional paradigm (2001) (234)
Factor IX is activated in vivo by the tissue factor mechanism. (1990) (215)
Regulation of NF-κB, AP-1, NFAT, and STAT1 Nuclear Import in T Lymphocytes by Noninvasive Delivery of Peptide Carrying the Nuclear Localization Sequence of NF-κB p50 (1998) (187)
Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets (1980) (176)
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets. (1982) (166)
The Tax Oncoprotein of Human T-cell Leukemia Virus Type 1 Associates with and Persistently Activates IκB Kinases Containing IKKα and IKKβ* (1998) (148)
Noninvasive intracellular delivery of functional peptides and proteins. (1999) (142)
Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. (1993) (140)
Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. (1982) (137)
Formation and regulation of platelet and fibrin hemostatic plug. (1987) (134)
DETECTION OF FACTOR X ACTIVATION IN HUMANS (1989) (134)
Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. (1982) (133)
gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. (1982) (133)
Separation of human platelets from plasma proteins including factor VIII VWF by a combined albumin gradient-gel filtration method using HEPES buffer. (1978) (131)
Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* (2005) (114)
Nuclear Import of Proinflammatory Transcription Factors Is Required for Massive Liver Apoptosis Induced by Bacterial Lipopolysaccharide* (2004) (111)
Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs. (1996) (107)
Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction. (1983) (104)
Function of the Classical and Alternate Pathways of Human Complement in Serum Treated with Ethylene Glycol Tetraacetic Acid and MgCl2-Ethylene Glycol Tetraacetic Acid (1975) (100)
Adenosine diphosphate induces binding of von Willebrand factor to human platelets (1982) (98)
Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. (1998) (98)
Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. (1989) (97)
Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis. (1989) (97)
Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. (1998) (92)
New paradigms in sepsis: from prevention to protection of failing microcirculation (2015) (88)
Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces. (1991) (83)
PLATELET AGGREGATES IN PERIPHERAL AND CORONARY-SINUS BLOOD IN PATIENTS WITH SPONTANEOUS CORONARY-ARTERY SPASM (1980) (83)
Proteolytic Processing of NF-B/IB in Human Monocytes (1995) (81)
Role of the Nuclear Localization Sequence in Fibroblast Growth Factor-1-stimulated Mitogenic Pathways (*) (1996) (80)
ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets. (1984) (78)
Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor. (1979) (75)
Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18 (2016) (73)
Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. (2006) (69)
Peptide-directed Suppression of a Pro-inflammatory Cytokine Response* (2000) (66)
Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets. (1982) (65)
STAPHYLOCOCCAL CLUMPING WITH SOLUBLE FIBRIN MONOMER COMPLEXES (1967) (62)
Mechanisms Involved in Platelet Vessel Wall Interaction (1995) (60)
Platelet Aggregates in Ischemic Heart Disease (1980) (56)
Isolation of human platelets by albumin gradient and gel filtration. (1989) (55)
Membrane Changes in Human Platelets Induced by Lipopolysaccharide Endotoxin (1977) (55)
Affinity isolation and characterization of immunoglobulin G Fc fragment-binding glycoprotein from human blood platelets. (1979) (53)
Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle. (1982) (53)
Receptor/Transporter-independent Targeting of Functional Peptides across the Plasma Membrane* (2004) (52)
The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IkappaB kinases containing IKKalpha and IKKbeta. (1998) (51)
Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor. (2009) (49)
Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization. (1994) (47)
Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor* (2004) (46)
IκB Kinase Complex Is an Intracellular Target for Endotoxic Lipopolysaccharide in Human Monocytic Cells (1999) (46)
Cellular import of functional peptides to block intracellular signaling. (1997) (46)
Precipitation of Soluble Fibrin Monomer Complexes by Lysosomal Protein Fraction of Polymorphonuclear Leukocytes∗ (1969) (45)
A beta-turn is present in the 392-411 segment of the human fibrinogen gamma-chain. Effects of structural changes in this segment on affinity to antibody 4A5. (1992) (45)
Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion. (1976) (42)
Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin1 (2008) (42)
Endotoxin-sensitive membrane component of human platelets (1975) (40)
Structure of the fibrinogen γ‐chain integrin binding and factor XIIIa cross‐linking sites obtained through carrier protein driven crystallization (1999) (40)
INTERACTION OF FIBRINOGEN WITH STAPHYLOCOCCAL CLUMPING FACTOR AND WITH PLATELETS * (1983) (39)
The integrin alpha v gene: identification and characterization of the promoter region. (1994) (39)
Complex formation of platelet membrane glycoproteins IIb and IIIa with the fibrinogen D domain. (1984) (39)
Interaction of human fibrinogen with staphylococci: presence of a binding region on normal and abnormal fibrinogen variants and fibrinogen derivatives. (1978) (33)
Platelet aggregation by fibrinogen polymers crosslinked across the E domain. (1986) (33)
Decoding inflammation, its causes, genomic responses, and emerging countermeasures (2019) (32)
Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota. (1986) (32)
Adhesive ends of fibrinogen and its antiadhesive peptides: the end of a saga? (1995) (32)
Targeting Nuclear Import Shuttles, Importins/Karyopherins alpha by a Peptide Mimicking the NFκB1/p50 Nuclear Localization Sequence (2013) (32)
Interaction of platelets with the vessel wall (1985) (32)
Structural characterization of monophosphoryl lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide. (1990) (31)
Modulation of human platelet protein kinase C by endotoxic lipid A. (1988) (31)
y and a chains of human fibrinogen possess sites reactive with human platelet receptors (29)
Adhesive Interactions of Platelets and Their Blockade a (1991) (28)
Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen. (1989) (27)
Platelet secretory pathways: an overview. (1989) (26)
Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix. (1991) (26)
Fibrinogen-mediated epidermal cell migration: structural correlates for fibrinogen function. (1989) (26)
Interaction of Histoplasma capsulatum with human platelets. (1980) (25)
Extended Anti-inflammatory Action of a Degradation-resistant Mutant of Cell-penetrating Suppressor of Cytokine Signaling 3* (2010) (25)
Purification and Properties of Lysozyme Produced by Staphylococcus aureus (1968) (25)
The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs. (1983) (24)
Nuclear Transport Modulation Reduces Hypercholesterolemia, Atherosclerosis, and Fatty Liver (2013) (22)
Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN-γ Signaling (2009) (22)
Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions* (2016) (21)
IkappaB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. (1999) (20)
COMPLEMENT-DEPENDENT PLATELET INJURY BY STAPHYLOCOCCAL PROTEIN A (1972) (20)
Human fibrinogen possesses binding site for staphylococci on Aα and Bβ polypeptide chains (1975) (20)
Frequency of staphylococcal lysozyme production tested by plate method (1968) (20)
In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes (2010) (19)
The “Genomic Storm” Induced by Bacterial Endotoxin Is Calmed by a Nuclear Transport Modifier That Attenuates Localized and Systemic Inflammation (2014) (18)
The Innate Immunity Adaptor SARM Translocates to the Nucleus to Stabilize Lamins and Prevent DNA Fragmentation in Response to Pro-Apoptotic Signaling (2013) (17)
Binding of fibrinogen and von Willebrand factor to platelet glycoprotein IIb-IIIa complex. (1992) (17)
Electron Microscopy of Fibrin‐like Precipitate Formed during the Paracoagulation Reaction between Soluble Fibrin Monomer Complexes and Protamine Sulphate (1969) (17)
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C. (1990) (17)
Cutting Edge: The “Death” Adaptor CRADD/RAIDD Targets BCL10 and Suppresses Agonist-Induced Cytokine Expression in T Lymphocytes (2012) (16)
How to approach genome wars in sepsis? (2011) (16)
Interaction of Artificial Phospholipid Membranes with Isolated Polymorphonuclear Leucocytic Granules (1969) (16)
Heartfelt sepsis: microvascular injury due to genomic storm. (2018) (15)
Macromolecules That Link Platelets following Vessel Wall Injury a (1987) (15)
Endotoxic lipid A interaction with human platelets. Structure-function analysis of lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide. (1990) (15)
Repertoire of platelet receptors. (1992) (15)
von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation. (1986) (15)
Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators. (1995) (14)
Platelets : receptors, adhesion, secretion (1989) (13)
Activation and release of lysosomal enzymes from isolated leukocytic granules by liposomes. A proposed model for degranulation in polymorphonuclear leukocytes. (1969) (10)
Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods. (1973) (10)
Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles (2017) (10)
Staphylococcal Clumping and Fibrinogen and Fibrin Degradation Products in Inflammatory Exudate 1 (1971) (10)
The Adaptor CRADD/RAIDD Controls Activation of Endothelial Cells by Proinflammatory Stimuli* (2014) (10)
Complement and Coagulation in Rocky Mountain Spotted Fever (1973) (10)
The resistance to antibiotics of strains of Staphylococcus aureus isolated in Poland. (1966) (9)
Reactivity of chemically cross-linked fibrinogen and its fragments D toward the staphylococcal clumping receptor. (1987) (9)
Sensitivity of Staphylococcus aureus to 30 antibiotics. (1969) (8)
ON THE IMMUNOLOGIC NATURE OF ANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS. (1964) (8)
Lethality in a Murine Model of Pulmonary Anthrax is Reduced by Combining Nuclear Transport Modifier with Antimicrobial Therapy (2012) (8)
Antibiotic sensitivity of Micrococcus radiodurans. (1967) (7)
Platelet Activation by Polyalkyl Acrylates and Methacrylates: The Role of Surface-Bound Fibrinogen (1987) (6)
Report of the Task Force on Vascular Medicine. (1994) (6)
Regulation of NFk B , AP-1 , NFAT , and STAT 1 Nuclear Import in T Lymphocytes by Noninvasive Delivery of Peptide Carrying the Nuclear Localization Sequence of NFk B p 501 (1998) (6)
Mechanism triggering platelet hemostatic plug formation in vivo. (1984) (6)
Disseminated intravascular coagulation in patients with infections: diagnostic and therapeutic approach. (1976) (5)
CRYOCOAGULOPATHY WITH PRESENCE OF IMMUNOANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS. (1964) (5)
EGF receptor–mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling (2020) (5)
Activation of lysosomal enzymes in polymorphonuclear leukocytic granules: the role of phospholipid-protein interaction. (1972) (4)
Dynamic changes in the membrane of leukocyte lysosomes detected with fluorescent probe and accompanied by release of lysosomal enzymes. (1973) (4)
The resistance to antibiotics of strains of Streptococcus viridans, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Proteus and Klebsiella isolated in Poland. (1966) (3)
Lipopolysaccharide-induced signal transduction and gene transcription (1994) (3)
Purification andProperties ofLysozyme Produced byStaphylococcus aureus (1968) (3)
The Role of Membrane Receptors in Pathways of Human Platelet Activation by Endotoxin and other Microbial Products (1975) (3)
Human fibrinogen possesses binding site for staphyococci on Aalpha and Bbeta polypeptide chains. (1975) (2)
Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles (2021) (2)
The Receptor For Factor VIII/VWF On Human Platelets: Its Appearance And Disappearance Upon Action Of Thrombin And Prostacyclin (1981) (2)
Protection from Endotoxin Shock by Selective Targeting of Proinflammatory Signaling to the Nucleus Mediated by Importin Alpha 5 (2019) (2)
Genomic control of inflammation in experimental atopic dermatitis (2022) (1)
Symposium on hemostasis: molecular and cellular pathology (1987) (1)
Introduction to platelet structural and functional organization. (1992) (1)
Proceedings: Pathobiology of human fibrinogen. Binding site for staphylococci on Aalpha and Bbeta chains of fibrinogen molecule. (1975) (1)
Frequency ofstaphylococcal lysozyme production tested byplate method (1968) (1)
REGULATION OF FIBRINOGEN RECEPTOR ON HUMAN PLATELETS BY CHANGES IN PLATELET CYCLIC AMP LEVELS * (1983) (1)
[Staphylococcal lysozyme. II. Purification of lysozyme produced by Staphylococcus aureus 524]. (1968) (1)
Antibiotic Sensitivity ofMicrococcus radiodurans (1967) (0)
Nuclear Localization Sequence of NF-Noninvasive Delivery of Peptide Carrying the STAT 1 Nuclear Import in T Lymphocytes by B , AP-1 , NFAT , and κ Regulation of NF - (1998) (0)
Immunology at vanderbilt university (2001) (0)
to the interaction of human endothelial cells with extracellular matrix Reactivity of synthetic peptide analogs of adhesive proteins in regard (2011) (0)
Cell-permeable peptide to inhibit inflammatory responses and their use (2000) (0)
The Role Of Fc Fragment Receptor in Immune Injury of Human Platelets Induced by Protein a of Staphylococci (1977) (0)
PLATELET RECEPTOR RECOGNITION DOMAINS AND THEIR SYNTHETIC PEPTIDE ANALOGS (1987) (0)
[Synthesis and lysis of the cell wall of staphylococci]. (1968) (0)
5. 3D-structure of human fibrinogen gamma chain ???business end??? interacting with platelet integrin GPIIb-IIIa and factor XIIIa (1998) (0)
Expression in T Lymphocytes Suppresses Agonist-Induced Cytokine CRADD/RAIDD Targets BCL10 and Cutting Edge: The ''Death'' Adaptor (2012) (0)
Kinase Complex Is an Intracellular Target for Endotoxic Lipopolysaccharide in Human Monocytic Cells (1999) (0)
derivatives region on normal and abnormal fibrinogen variants and fibrinogen Interaction of human fibrinogen with staphylococci: presence of a binding (2012) (0)
A stand-off between rhAPC and LPS in healthy human subjects (2003) (0)
Effect ofVegetarianism andSmoking onVitamin B12, Thiocyanate, andFolate Levels intheBloodofNormal Subjects (1972) (0)
United States Patent ( 19 ) Stuttle 54 SYNTHETICPEPTIDES FOR USE IN TUMOR DETECTION (2017) (0)
United States Patent ( 19 ) Charo et al . 54 PEPTIDES DERIVED FROM GPA ( 75 ) Inventors : Israel (2017) (0)
Adhesive interactions of platelets and their blockade with synthetic peptides (1990) (0)
mutant Re595 of Salmonella minnesota Mechanism of human platelet activation by endotoxic glycolipid-bearing (2011) (0)
Platelet receptor recognition domain on the .gamma. chain of human fibrinogen and its synthetic peptide analogs [Erratum to document cited in CA110(17):151810E] (1989) (0)
Three-dimensional structure of the platelet integrin recognition (2004) (0)
The inducible nuclear import of NF-κB, AP-1, and NF-AT in stimulated human T-lymphocytes (1996) (0)
Peptide/Protein Delivery (2002) (0)
Platelets : Vol. 215, Pt. B: Receptors, Adhesion, Secretion (1992) (0)
Cellular import of functional peptides (2002) (0)
Activation ofLysosomal Enzymes inPolymorphonuclear Leukocytic Granules: TheRoleofPhospholipid-Protein Interaction* (1972) (0)
Structural characterization of the recognition site for platelet receptors on human fibrinogen (1985) (0)
Aggregation of human platelets by endotoxic glycolipid-bearing Salmonella minnesota Re595 is prevented by synthetic peptide analogs of cell adhesion sites of fibrinogen and fibronectin (1986) (0)
Separation of Human Blood Platelets from Factor VIII (Von Willebrand’s Factor) by Combined Albumin Gradient-Gel Filtration Method (1977) (0)
Functional maturation of invariant natural T (iNKT) cells is under the control of GM-CSF (2006) (0)
Pathobiology of Human Fibrinogen. Binding site for Staphylococci on Aα and Bβ chains of Fibrinogen Molecule (1975) (0)
Shiga Toxin Capture by Endothelium in Response to Fractalkine and CX3CR1 Mediate Leukocyte (2008) (0)
Importin Alpha 5 Proinflammatory Signaling to the Nucleus Mediated by Protection from Endotoxin Shock by Selective Targeting of (2019) (0)
[Antibiotic treatment: errors and suggestions]. (1967) (0)
ON SOME ASPECTS OF THE ANTIBODIES DEFICIENCY SYNDROME. (1963) (0)
REGULATION OF PLATELET RECEPTORS FOR FIBRINOGEN AND VON WILLEBRAND FACTOR BY PROTEIN KINASE (1987) (0)
[Staphylococcal lysozyme. 3. Factors influencing the course of reaction of staphylococcal lysozyme]. (1968) (0)
The Regulatory Role Of Camp In Induction Of Human Platelet Receptor For Fibrinogen (1981) (0)
[THE ANTIBODY DEFICIENCY SYNDROME AND MUCOVISCIDOSIS]. (1963) (0)
A method for preventing the binding of von Willebrand factor to human platelets and to stimulate the interaction of platelets with vessel walls. (1985) (0)
[Intradepartmental infection in a children's clinic]. (1969) (0)
Immune Injury to Human Platelets Mediated By IgG Fc Receptor is Prevented by Prostacyclin (1979) (0)
[THE ANTIBODY DEFICIENCY SYNDROME AND MUCOVISCIDOSIS]. (1963) (0)
A method for the prevention and induction of human platelet aggregation. (1985) (0)
Dr. Mario Baldini (January 15, 1917-August 4, 1986). (1987) (0)
Demonstration of the platelet Fc receptor by using a photosensitive heterobifunctional cross-linking reagent (1986) (0)
Inhibition of adhesive receptors: Research initiatives in vascular surgery * (1989) (0)
METHODS AND COMPOSITIONS FOR TREATING MICROBIAL INFLAMMATION (2018) (0)
[Staphylococcal lysozyme. 4. Lysozyme activity towards various substrates]. (1968) (0)
[Susceptibility of Staphylococcus aureus to the effect of 30 antibiotics in vitro]. (1969) (0)
Mobilization of Fibrinogen Receptor Sites on Human Platelets Stimulated with ADP is Prevented by Prostacyclin (1979) (0)
[Staphylococcal lysozyme. I. Occurrence of lysozyme in comparison with the other staphylococcal factors]. (1967) (0)
Expression Of The Fc Receptor On Human Platelets Is Regulated By Cyclic Amp Changes (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jacek J. Hawiger?

Jacek J. Hawiger is affiliated with the following schools: